Market Analysis — Saturday, December 27, 2025

Validated price 40.51 is above our cost and supports keeping the position. As a healthcare plan operator, CNC can re-rate if medical cost trends stabilize and margins normalize; risk exists (policy/rates), but valuation and position size warrant holding rather than taking profits early.

Validated price 48.41 shows modest appreciation vs cost. FITB remains a reasonably valued regional bank; holding is justified as long as credit costs and deposit competition remain manageable and earnings power holds up through the cycle.

Validated price 99.55 implies a gain vs our cost basis. Target is a mature cash-generative retailer; the position size is small, and holding keeps exposure to potential margin normalization and steady shareholder returns without taking excess risk.

At validated price 81.56, FTNT is near our entry and remains fundamentally attractive: cybersecurity demand is structural and Fortinet’s margin profile supports long-term compounding if execution continues. No evidence of fundamental deterioration from the available market data; holding is prudent.

With validated price 113.56 (above cost), Disney remains a durable IP + parks platform where multi-year execution (streaming economics, studio slate normalization) can drive intrinsic value. Current position is moderate; no need to add aggressively without clearer margin/FCF visibility, but also no reason to exit on fundamentals alone.

At the validated price of 103.50, EOG is below our cost basis but still fits a fundamentally-driven, shareholder-return E&P profile (typically strong FCF generation through the cycle when capex is controlled). No tool-validated evidence of a thesis break; holding is appropriate given commodity cyclicality and long-term cash return potential.

CME’s business model (derivatives exchange + clearing) is structurally advantaged with strong operating leverage and historically resilient margins. With the latest validated price at 276.73, nothing indicates fundamental impairment; keeping exposure supports steady compounding and diversification within financials.

Clear trend support, positive sector inertia, and risk/reward remains in favor of further advance.

Momentum and technical structure favor trend continuation. No reversal/weakness evidence.

Consistent growth and technical stability support a hold; no breakdown or extended overbought signs.

Price sits at top end of prior resistance zone amid market leadership. Risk/reward skews positive given broader tech strength.

LNT is stable, showing no strong downtrend. Sector rotation could favor utilities if overall market encounters volatility. Protection against broader drawdowns and mild loss not a concern at present.

TSLA is holding above key support ($470-$475), and no technical sell signal is present. Broader market flows and sector rotation could lead to renewed upward momentum, justifying a continued hold.

AMAT is above both 50- and 200-day moving averages, and relative strength is strong, with sector ETF flows positive. Maintain exposure for potential further gains.

CRM displays strong relative strength (RSI not in overbought), and the sentiment in software remains positive. Riding further medium-term upside unless reversal materializes.

Uptrend is intact with no major reversal signs. Volume is healthy and price approaches the analyst target. This swing position still offers asymmetric risk-reward to the upside.